ID

DB08965||

名称

Fusafungine

描述

Fusafungine is an antibiotic from Fusarium lateririum, and is used for the treatment of respiratory infections.

cas号

1393-87-9

唯一标识码

65DD690W0C

状态

solid

组

approved,withdrawn,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating.
direct-parent:Cyclic depsipeptides
kingdom:Organic compounds
superclass:Organic acids and derivatives
class:Peptidomimetics
subclass:Depsipeptides
alternative-parent:Alpha amino acid esters
alternative-parent:Azacyclic compounds
alternative-parent:Carbonyl compounds
alternative-parent:Carboxylic acid esters
alternative-parent:Hydrocarbon derivatives
alternative-parent:Lactams
alternative-parent:Lactones
alternative-parent:Macrolactams
alternative-parent:Macrolide lactams
alternative-parent:Macrolides and analogues
alternative-parent:Organic oxides
alternative-parent:Organonitrogen compounds
alternative-parent:Organopnictogen compounds
alternative-parent:Oxacyclic compounds
alternative-parent:Tertiary carboxylic acid amides
alternative-parent:Tricarboxylic acids and derivatives
substituent:Aliphatic heteromonocyclic compound
substituent:Alpha-amino acid ester
substituent:Alpha-amino acid or derivatives
substituent:Azacycle
substituent:Carbonyl group
substituent:Carboxamide group
substituent:Carboxylic acid derivative
substituent:Carboxylic acid ester
substituent:Cyclic depsipeptide
substituent:Hydrocarbon derivative
substituent:Lactam
substituent:Lactone
substituent:Macrolactam
substituent:Macrolide
substituent:Macrolide lactam
substituent:Organic nitrogen compound
substituent:Organic oxide
substituent:Organic oxygen compound
substituent:Organoheterocyclic compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Oxacycle
substituent:Tertiary carboxylic acid amide
substituent:Tricarboxylic acid or derivatives

消除途径

种类

Amino Acids, Peptides, and Proteins
D000602
Anti-Bacterial Agents
D000900
Anti-Infective Agents
D000890
Peptides
D010455
Peptides, Cyclic
D010456
Throat Preparations

盐类

蛋白质结合

清除

同义词

language:spanish; code:; name;Fusafungina
language:english; code:inn/ban/dcf; name;Fusafungine

国际品牌

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

form:Solution
route:Nasal
strength:50 MG/5ML

atc代码

Antibiotics
THROAT PREPARATIONS
THROAT PREPARATIONS
RESPIRATORY SYSTEM

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB12768
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fusafungine.
DB00266
The risk or severity of bleeding can be increased when Fusafungine is combined with Dicoumarol.
DB00498
The risk or severity of bleeding can be increased when Fusafungine is combined with Phenindione.
DB00682
The risk or severity of bleeding can be increased when Fusafungine is combined with Warfarin.
DB00946
The risk or severity of bleeding can be increased when Fusafungine is combined with Phenprocoumon.
DB01418
The risk or severity of bleeding can be increased when Fusafungine is combined with Acenocoumarol.
DB03410
The risk or severity of bleeding can be increased when Fusafungine is combined with 4-hydroxycoumarin.
DB04665
The risk or severity of bleeding can be increased when Fusafungine is combined with Coumarin.
DB08496
The risk or severity of bleeding can be increased when Fusafungine is combined with (R)-warfarin.
DB08794
The risk or severity of bleeding can be increased when Fusafungine is combined with Ethyl biscoumacetate.
DB13136
The risk or severity of bleeding can be increased when Fusafungine is combined with Fluindione.
DB13275
The risk or severity of bleeding can be increased when Fusafungine is combined with Clorindione.
DB13347
The risk or severity of bleeding can be increased when Fusafungine is combined with Diphenadione.
DB13451
The risk or severity of bleeding can be increased when Fusafungine is combined with Tioclomarol.
DB14055
The risk or severity of bleeding can be increased when Fusafungine is combined with (S)-Warfarin.
DB14443
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fusafungine.

序列

实验性质

外部标识符

resource：PubChem Compound
identifier：3084092
resource：PubChem Substance
identifier：310264928
resource：ChemSpider
identifier：2341206
resource：Wikipedia
identifier：Fusafungine
resource：RxCUI
identifier：25437

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应